SCHEMBL2862178

SCHEMBL2862178

CCCCCCCCCCC(C)(c1ccc(O)cc1)c1ccc(O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 8/20 0.58
ESR2 Q92731 6/20 0.58
CYP3A4 P08684 3/20 0.53
ALDH1A1 P00352 2/20 0.53
SLC6A2 P23975 3/20 0.50
SLC6A4 P31645 3/20 0.50
SLC6A3 Q01959 3/20 0.50
ADRA2A P08913 2/20 0.50
ADORA3 P0DMS8 2/20 0.50
TACR2 P21452 2/20 0.50
LMNA P02545 2/20 0.50
HSD17B10 Q99714 2/20 0.50
KDM4E B2RXH2 1/20 0.50
SHBG P04278 1/20 0.50
TP53 P04637 1/20 0.50
HSPD1 P10809 1/20 0.50
ADRB3 P13945 1/20 0.50
HTR2C P28335 1/20 0.50
HSPE1 P61604 1/20 0.50
HIF1A Q16665 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4184704 1.00 ESR1 (0.58) ESR1ESR2CYP3A4ALDH1A1SLC6A2
SCHEMBL2150972 1.00 ESR1 (0.58) ESR1ESR2CYP3A4ALDH1A1SLC6A2
SCHEMBL74674 1.00 ESR1 (0.58) ESR1ESR2CYP3A4ALDH1A1SLC6A2
SCHEMBL339165 1.00 ESR1 (0.58) ESR1ESR2CYP3A4ALDH1A1SLC6A2
SCHEMBL10752629 1.00 ESR1 (0.58) ESR1ESR2CYP3A4ALDH1A1SLC6A2
SCHEMBL5029048 1.00 ESR1 (0.58) ESR1ESR2CYP3A4ALDH1A1SLC6A2
SCHEMBL10752311 1.00 ESR1 (0.58) ESR1ESR2CYP3A4ALDH1A1SLC6A2
SCHEMBL895364 1.00 ESR1 (0.58) ESR1ESR2CYP3A4ALDH1A1SLC6A2
SCHEMBL9472405 1.00 ESR1 (0.58) ESR1ESR2CYP3A4ALDH1A1SLC6A2
SCHEMBL2163700 1.00 ESR1 (0.58) ESR1ESR2CYP3A4ALDH1A1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062580-A1 REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT THE PILOT INK CO., LTD. (JP) 2026-03-05 US disclosed
EP-3954745-B1 REVERSIBLY THERMOCHROMIC AQUEOUS INK COMPOSITION FOR WRITING UTENSILS, AND REFILL AND WATER-BASED BALLPOINT PEN EACH INTERNALLY CONTAINING SAME KK PILOT CORPORATION ALSO TRADING AS PILOT CORPORATION (JP) 2026-01-07 EP disclosed
US-12460099-B2 Reversibly thermochromic composition, reversibly thermochromic microcapsule pigment encapsulating reversibly thermochromic composition, and writing instrument using reversibly thermochromic microcapsule pigment THE PILOT INK CO., LTD. (JP) 2025-11-04 US disclosed
US-12421411-B2 Aqueous ink composition for reversibly thermochromic writing instrument, and refill and aqueous ballpoint pen incorporating aqueous ink composition for reversibly thermochromic writing instrument KABUSHIKI KAISHA PILOT CORPORATION (JP) 2025-09-23 US disclosed
CN-119709173-A Reversible thermochromic composition and reversible thermochromic microcapsule pigment having the same encapsulated therein 百乐墨水株式会社 2025-03-28 CN disclosed
EP-3608386-B1 REVERSIBLY THERMOCHROMIC COMPOSITION, AND REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT HAVING SAME ENCLOSED THEREIN PILOT INK CO LTD (JP) 2025-02-19 EP disclosed
CN-119242290-A Reversible thermochromic composition and reversible thermochromic microcapsule pigment having the same encapsulated therein 百乐墨水株式会社 2025-01-03 CN disclosed
CN-116209725-B Reversible thermochromic composition and reversible thermochromic microcapsule pigment having the same encapsulated therein 百乐墨水株式会社 2024-12-31 CN disclosed
US-12123107-B2 Reversibly thermochromic composite fiber KABUSHIKI KAISHA PILOT CORPORATION (JP) 2024-10-22 US disclosed
US-12011943-B2 Image forming apparatus TOSHIBA TEC KABUSHIKI KAISHA (JP) 2024-06-18 US disclosed
EP-1270646-A1 RESIN COMPOSITION AND ARTICLES MOLDED THEREFROM TORAY INDUSTRIES, INC. (JP) 2003-01-02 EP disclosed
EP-0943640-A1 HIGHLY HEAT-RESISTANT, HIGH-PURITY POLYARYLATE AND FILM PRODUCED FROM THE SAME UNITIKA LTD. (JP) 1999-09-22 EP disclosed
EP-0941268-A1 POLYCARBONATES THE DOW CHEMICAL COMPANY (US) 1999-09-15 EP disclosed
US-5902872-A POLYARYLATE COMPRISING 2,2-BIS/3-METHYL-4-HYDROXYPHENYL/PROPANE UNITS, TEREPHTHALIC ACID UNITS AND ISOPHTHALIC ACID UNITS, HAVING SPECIFIED INHERENT VISCOSITY UNITIKA, LTD. (JP) 1999-05-11 US disclosed
EP-0884342-A1 Resin for coating formation and method for producing the same UNITIKA LTD. (JP) 1998-12-16 EP disclosed
WO-1998022522-A1 POLYCARBONATES THE DOW CHEMICAL COMPANY (US) 1998-05-28 WO disclosed
EP-0093320-B1 PROCESS FOR THE EXTRACTION OF ONIUM SALTS FROM PROCESS AND WASTE WATERS BAYER AG (DE) 1987-06-16 EP disclosed
US-4487698-A REMOVING QUATERNARY AMMONIUM AND PHOSPHONIM SALTS WITH PHENOLIC COMPOUNDS; PHASE TRANSFER BAYER AKTIENGESELLSCHAFT (DE) 1984-12-11 US disclosed
EP-0093320-A2 Process for the extraction of onium salts from process and waste waters BAYER AG (DE) 1983-11-09 EP disclosed
US-RE31165-E Transparent moulding composition of a polycarbonate and a resin BAYER AKTIENGESELLSCHAFT (DE) 1983-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062580-A1 REVERSIBLY THERMOCHROMIC COMPOSITION, REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT ENCAPSULATING REVERSIBLY THERMOCHROMIC COMPOSITION, AND WRITING INSTRUMENT USING REVERSIBLY THERMOCHROMIC MICROCAPSULE PIGMENT TYR, SCO2, HBB ESR1 4366/4885ESR2 3067/4885CYP3A4 1450/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.